Press releases
Livit by Nightingale Health reaches even more users
Mar 29, 2023
Company releases
Nightingale Health Plc’s Auditor to Change
Mar 24, 2023
Company releases
Nightingale Health Group’s Half-year report 1 July 2022 – 31 December 2022: Commercialization progressing in line with strategy
Mar 23, 2023
Company releases
Nightingale Health Plc: Unaudited financial information in accordance with IFRS for the comparative half-year periods
Mar 22, 2023
Company releases
Notice to the Extraordinary General Meeting of Nightingale Health Plc
Mar 17, 2023
Press releases
Nightingale Health to publish half-year report for July – December 2022 on 23 March 2023
Mar 15, 2023
Press releases
Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200,000 Estonian Biobank samples
Mar 08, 2023
Managers' transactions
Nightingale Health Plc – Managers’ transactions – Olli Karhi
Feb 14, 2023
Press releases
Nightingale Health combines genetics with its unique blood test results in Livit by Nightingale Health service
Feb 03, 2023
Company releases
Inside information: Nightingale Health acquires worldwide license for blood self-collection device Velvet™
Jan 31, 2023
Company releases
Nightingale Health to open laboratory in the United Kingdom in 2023
Jan 25, 2023
Company releases
Conversion of Nightingale Health Plc’s Series A shares to Series B shares
Dec 22, 2022
Managers' transactions
Nightingale Health Plc – Managers’ transactions – Leena Niemistö
Nov 29, 2022
Managers' transactions
Nightingale Health Plc – Managers’ transactions – Leena Niemistö
Nov 29, 2022
Company releases
Change in the publication date of Nightingale Health Plc’s half-year financial report for the period 1 July – 31 December 2022
Nov 17, 2022
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15